National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

Overview

Journal Int J Part Ther

Publisher Elsevier

Specialty Radiology

Date 2021 Jul 21

PMID 34285961

Citations 15

Authors

Johannes A Langendijk

Frank J P Hoebers

Martin A de Jong

Patricia Doornaert

Chris H J Terhaard

Roel J H M Steenbakkers

Olga Hamming-Vrieze

Jeroen B Van de Kamer

Wilko F A R Verbakel

Fatma Keskin-Cambay

Johannes B Reitsma

Arjen van der Schaaf

Liesbeth J Boersma

Ewoud Schuit

Affiliations

Soon will be listed here.

Abstract

In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

Citing Articles

Hsuan Chen Y, Kroesen M, Hoogeman M, Versteegh M, Uyl-de Groot C, Blommestein H Clin Transl Radiat Oncol. 2025; 51:100913.

PMID: 39898329 PMC: 11787426. DOI: 10.1016/j.ctro.2025.100913.

Clinical Introduction of Stem Cell Sparing Radiotherapy to Reduce the Risk of Xerostomia in Patients with Head and Neck Cancer.

van Rijn-Dekker M, van der Schaaf A, Nienhuis S, Arents-Huls A, Ger R, Hamming-Vrieze O Cancers (Basel). 2025; 16(24.

PMID: 39766181 PMC: 11674908. DOI: 10.3390/cancers16244283.

Artificial intelligence research in radiation oncology: a practical guide for the clinician on concepts and methods.

Hoebers F, Wee L, Likitlersuang J, Mak R, Bitterman D, Huang Y BJR Open. 2024; 6(1):tzae039.

PMID: 39583148 PMC: 11585305. DOI: 10.1093/bjro/tzae039.

Sinonasal Squamous Cell Carcinoma in the Netherlands: A Population-Based Study of 568 Cases Diagnosed in 2008-2021.

van de Velde L, Scheurleer W, Braunius W, Speksnijder C, de Ridder M, Devriese L Head Neck. 2024; 47(2):695-705.

PMID: 39412961 PMC: 11717970. DOI: 10.1002/hed.27961.

Clinical advantages of incorporating predicted weekly anatomy in IMPT optimization with reduced setup error.

Zhang Y, Chan M Med Phys. 2024; 51(12):9207-9216.

PMID: 39298742 PMC: 11656292. DOI: 10.1002/mp.17412.

References

Christianen M, van der Schaaf A, van der Laan H, Verdonck-de Leeuw I, Doornaert P, Chouvalova O . Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach. Radiother Oncol. 2015; 118(2):298-303. DOI: 10.1016/j.radonc.2015.11.009. View

Langendijk J, Lambin P, De Ruysscher D, Widder J, Bos M, Verheij M . Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013; 107(3):267-73. DOI: 10.1016/j.radonc.2013.05.007. View

Lee T, Fang F . Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy. Radiother Oncol. 2013; 106(3):352-8. DOI: 10.1016/j.radonc.2012.11.013. View

Dean J, Welsh L, Wong K, Aleksic A, Dunne E, Islam M . Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. Clin Oncol (R Coll Radiol). 2017; 29(4):263-273. PMC: 6175048. DOI: 10.1016/j.clon.2016.12.001. View

Mazzola R, Ricchetti F, Fiorentino A, Fersino S, Giaj Levra N, Naccarato S . Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment. Br J Radiol. 2014; 87(1044):20140543. PMC: 4243212. DOI: 10.1259/bjr.20140543. View

Lee T, Chao P, Ting H, Chang L, Huang Y, Wu J . Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of Xerostomia after intensity-modulated radiotherapy for head and neck cancer. PLoS One. 2014; 9(2):e89700. PMC: 3938504. DOI: 10.1371/journal.pone.0089700. View

Beetz I, Schilstra C, van Luijk P, Christianen M, Doornaert P, Bijl H . External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy. Radiother Oncol. 2011; 105(1):94-100. DOI: 10.1016/j.radonc.2011.11.006. View

Vergouwe Y, Nieboer D, Oostenbrink R, Debray T, Murray G, Kattan M . A closed testing procedure to select an appropriate method for updating prediction models. Stat Med. 2016; 36(28):4529-4539. DOI: 10.1002/sim.7179. View

Vlacich G, Spratt D, Diaz R, Phillips J, Crass J, Li C . Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer. Radiother Oncol. 2014; 110(3):435-40. DOI: 10.1016/j.radonc.2013.12.007. View

10.

Van den Bosch L, Schuit E, van der Laan H, Reitsma J, Moons K, Steenbakkers R . Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy. Radiother Oncol. 2020; 148:151-156. DOI: 10.1016/j.radonc.2020.04.012. View

11.

Brouwer C, Steenbakkers R, Bourhis J, Budach W, Grau C, Gregoire V . CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol. 2015; 117(1):83-90. DOI: 10.1016/j.radonc.2015.07.041. View

12.

Sanguineti G, Gunn G, Parker B, Endres E, Zeng J, Fiorino C . Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2010; 79(1):52-9. DOI: 10.1016/j.ijrobp.2009.10.057. View

13.

Tambas M, Steenbakkers R, van der Laan H, Wolters A, Kierkels R, Scandurra D . First experience with model-based selection of head and neck cancer patients for proton therapy. Radiother Oncol. 2020; 151:206-213. DOI: 10.1016/j.radonc.2020.07.056. View

14.

Marzi S, Iaccarino G, Pasciuti K, Soriani A, Benassi M, Arcangeli G . Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2009; 73(4):1252-9. DOI: 10.1016/j.ijrobp.2008.11.020. View

15.

Wopken K, Bijl H, van der Schaaf A, van der Laan H, Chouvalova O, Steenbakkers R . Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer. Radiother Oncol. 2014; 113(1):95-101. DOI: 10.1016/j.radonc.2014.09.013. View

16.

Strigari L, Pedicini P, DAndrea M, Pinnaro P, Marucci L, Giordano C . A new model for predicting acute mucosal toxicity in head-and-neck cancer patients undergoing radiotherapy with altered schedules. Int J Radiat Oncol Biol Phys. 2012; 83(5):e697-702. DOI: 10.1016/j.ijrobp.2012.02.004. View

17.

Buettner F, Miah A, Gulliford S, Hall E, Harrington K, Webb S . Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial. Radiother Oncol. 2012; 103(1):82-7. DOI: 10.1016/j.radonc.2012.02.006. View

18.

Beetz I, Schilstra C, van der Schaaf A, van den Heuvel E, Doornaert P, van Luijk P . NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. Radiother Oncol. 2012; 105(1):101-6. DOI: 10.1016/j.radonc.2012.03.004. View

19.

Dean J, Wong K, Welsh L, Jones A, Schick U, Newbold K . Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy. Radiother Oncol. 2016; 120(1):21-7. PMC: 5021201. DOI: 10.1016/j.radonc.2016.05.015. View

20.

Sapir E, Tao Y, Feng F, Samuels S, El Naqa I, Murdoch-Kinch C . Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016; 96(2):354-361. DOI: 10.1016/j.ijrobp.2016.05.011. View